000 01013nam a2200289 a 4500
005 20250914142610.0
008 040604s2004 nyua b 001 0 eng
020 _a0824753208 (alk. paper)
_cRM743.60
039 9 _a200602221219
_brapiza
_c200602151437
_drazalis
_y02-15-2006
_zrazalis
060 _aWA730
090 _aWA730.M6253 2004
245 0 0 _aMicrobial contamination control in parenteral manufacturing /
_cedited by Kevin L. Williams
260 _aNew York :
_bMarcel Dekker,
_c2004
300 _axxvi, 721 p. :
_bill. ;
_c24 cm.
440 0 _aDrugs and the pharmaceutical sciences ;
_vv. 140
650 2 _aDrug Contamination
_xprevention & control
650 2 _aMicrobiology
650 2 _aDrug Industry
_xmethods
700 1 _aWilliams, Kevin L.
907 _a.b13675825
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kWA730.M6253 2004
914 _avtls003321553
990 _azaa
991 _aJabatan Farmasi, KKL
998 _ad
_b2006-02-02
_cm
_da
_feng
_gnyu
_y0
_z.b13675825
999 _c366232
_d366232